Lutetium (177Lu) oxodotreotide (INN) or 177Lu dotatate, brand name Lutathera, is a chelated complex of a radioisotope of the element lutetium with dotatate...

patients being treated with Lutathera experienced either complete or partial tumor shrinkage. FDA approval of Lutathera was ultimately supported by two...

between Lutathera and Pluvicto is shown in the chemical linkages in the images above. The production, transportation, and storage is the same as Lutathera. The...

treatment position. When the radionuclides are ligands (such as with Lutathera and Pluvicto), the technique is also known as radioligand therapy. Iodine-131...

Lutetium (177Lu) oxodotreotide, also known as Lutetium (177Lu) dotatate ("Lutathera"), has been approved for some types of tumors. 3) Lutetium (177Lu) vipivotide...

treat thyroid cancer or thyrotoxicosis, of peptide-bound lutetium-177 (Lutathera) and yttrium-90 to treat neuroendocrine tumors (peptide receptor radionuclide...

hydrochloride (USAN) lurosetron (INN) lurtotecan (INN) lusupultide (USAN) Lutathera lutrelin (INN) Lutrepulse Kit lutropin alfa (INN) Luvox luxabendazole...

volume production of the relevant radionuclides is high. The cost of Lutathera, a commercial 177Lu-DOTATATE product, has been quoted by the manufacturer...

Novartis, it is part of their radiopharmaceutical portfolio, alongside Lutathera and Pluvicto. "lutetium lu 177-neob". My Cancer Genome. Retrieved 2025-05-21...